Tommaso Falcone is Executive Vice President and President of International and Emerging Markets at Cleveland Clinic. In this role, Dr. Falcone leads and executes Cleveland Clinic’s strategic initiatives in established and emerging international markets. This includes overseeing enterprise-wide Global Patient Services, International Operations, Cleveland Canada, and Cleveland Clinic Nevada. He also works closely with leaders at Cleveland Clinic London and Cleveland Clinic Abu Dhabi.
Previously, Dr. Falcone served as Chief of Staff at Cleveland Clinic London before becoming its interim president in June 2023.
Dr. Falcone graduated from McGill University School of Medicine in Montreal, Quebec. He then completed a residency in obstetrics and gynecology and a fellowship in reproductive endocrinology at McGill. He is certified by the American Board of Obstetrics and Gynecology and by the Royal College of Physicians and Surgeons of Canada. He was also appointed Fellow (ad eundem) of the Royal College of Obstetricians and Gynaecologists of the United Kingdom.
Dr. Falcone has held leadership roles in national and international surgical societies and continues to serve as a Professor of Obstetrics, Gynecology, and Reproductive Biology at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Falcone is the senior author of the first publication in the world on gynecologic robotic surgery and is a member of the team that performed the first uterus transplant in the U.S.